{"success":true,"data":{"pressRelease":{"id":"109034","rtpr_id":"nPn4L5Gp1a","ticker":"EPC","exchange":"NYSE","all_tickers":["EPC"],"title":"Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results","author":"PR Newswire","published_at":"2026-08-05T10:00:00.750Z","article_body":"Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results\n\nPR Newswire\n\nSHELTON, Conn., Aug. 5, 2026\n\nOrganic Net Sales Returned to Growth; North America Performance Improved\nMeaningfully\n\nAdjusted EPS and Adjusted EBITDA Exceeded Expectations\n\nFull Year Outlook Narrowed; Mid-points for Adjusted EPS and Adjusted EBITDA\nRemain Unchanged\n\nSHELTON, Conn., Aug. 5, 2026 /PRNewswire/ -- Edgewell Personal Care Company\n(NYSE: EPC) today announced results for its third fiscal quarter 2026 ended\nJune 30, 2026.\n\nExecutive Summary\n\n * Third quarter net sales were $570.1 million, an increase of 1.7% compared to\nthe prior year quarter.\n * Organic net sales increased 1.1%. (Organic basis excludes the impact from\ncurrency movements.)\n * GAAP Diluted net Earnings Per Share (\"EPS\") were $0.26, compared to $0.46 in\nthe prior year quarter.\n * Adjusted EPS were $0.72 for the quarter, compared to $0.72 in the prior year\nquarter.\n * Ended the third quarter with $397.1 million in cash on hand, access to an\nadditional $418.8 million under the Company's U.S. revolving credit facility\navailable.\n * Returned $7.0 million to shareholders in the form of dividends in the third\nquarter.\n * The Board of Directors declared a cash dividend of $0.15 per common share on\nAugust 5, 2026, for the third quarter.\n\"Our third quarter results represent an important step forward in our fiscal\n2026 progression, with organic net sales returning to growth, meaningful\nimprovement in North America, and adjusted EPS and adjusted EBITDA ahead of\nexpectations,\" said Rod Little, Edgewell's President and Chief Executive\nOfficer. \"At the beginning of the year, we anticipated that fiscal 2026 would\nbe a back-half story, and based on our current outlook, we remain on track to\ndeliver on that commitment. Our priority brands continue to gain traction, and\nwe believe that the investments we have made are strengthening our\ncapabilities and improving business performance. We are increasingly confident\nin the trajectory of the business and the foundation we are building for\nfuture growth and value creation.\"\n\nUnless otherwise noted, reported results in this release are based on\ncontinuing operations and exclude the Feminine Care business which is treated\nas discontinued operations. The Company reports and forecasts results on a\nGAAP and non-GAAP basis and has reconciled non-GAAP results and outlook to the\nmost directly comparable GAAP measures later in this release. See non-GAAP\nFinancial Measures for a more detailed explanation, including definitions of\nvarious non-GAAP terms used in this release. All comparisons used in this\nrelease are for the same period in the prior fiscal year unless otherwise\nstated.\n\nFiscal 3Q 2026 Operating Results (Unaudited)\n\nNet sales were $570.1 million in the quarter, an increase of $9.7 million, or\n1.7%, including a $3.6 million, or 0.6% favorable impact from currency\nmovements. Organic net sales increased $6.1 million, or 1.1%, reflecting a\nreturn to growth in North America, partially offset by lower sales in\ninternational markets. North America organic sales increased 3.0%, driven by\nvolume growth across Sun, Skin Care and Grooming, reflecting improving\nexecution, increased distribution and continued strength across several of the\nCompany's priority brands. International organic sales declined 1.4%,\nprimarily reflecting temporary disruption associated with the conflict in the\nMiddle East and short-term supply chain impacts related to the Company's Wet\nShave manufacturing consolidation, partially offset by growth in Grooming and\nseveral key international markets.\n\nGross profit was $242.5 million, as compared to $250.1 million in the prior\nyear quarter. Gross margin as a percent of net sales was 42.5%,a decrease of\n210-basis points. Adjusted gross margin as a percent of net sales decreased\n30-basis points, to 44.5% in the quarter. Productivity savings of\napproximately 200-basis points and 40-basis points of favorable currency\nmovements were more than offset by 160-basis points of core inflation and net\ntariffs and 110-basis points of unfavorable mix and promotional levels (net of\npricing).\n\nAdvertising and sales promotion expense (\"A&P\") was $83.2 million, or\n14.6% of net sales, an increase of $7.2 million, compared to $76.0 million, or\n13.6% of net sales in the prior year quarter.\n\nSelling, general and administrative expense (\"SG&A\") was $108.3 million,\nor 19.0% of net sales, as compared to $100.7 million, or 18.0% of net sales in\nthe prior year quarter. Adjusted SG&A was 18.4% of net sales, compared to\n17.6% in the prior year quarter which was primarily driven by higher incentive\ncompensation expense and unfavorable currency impacts in the current year,\npartly offset by lower people and consulting expenses.\n\nThe Company recorded pre-tax restructuring and related costs in support of\ncost efficiency and effectiveness programs of $24.5 million in the quarter.\n\nOperating income was $25.0 million, or 4.4% of net sales, inclusive of a $2.6\nmillion, or 40-basis points impact from favorable currency movements, compared\nto income of $45.0 million, or 8.0% of net sales in the prior year quarter.\nAdjusted operating income was $53.0 million, or 9.3% of net sales, compared to\n$63.6 million, or 11.3% of net sales in the prior year quarter.\n\nInterest expense associated with debt was $16.7 million, compared to $19.4\nmillion in the prior year quarter. The decrease in interest expense was the\nresult of lower borrowing levels on the Company's U.S. revolving credit\nfacility due to the paydown of the facility with the proceeds of the Feminine\nCare divestiture.\n\nOther (income) expense, net was income of $9.7 million compared to income of\n$2.9 million in the prior year quarter. The current year quarter included $7.7\nmillion of Transition Services Agreement (\"TSA\") income. Additionally, the\nprior year quarter included $2.7 million of other project gains. Currency\nhedge and remeasurements gains were $0.6 million in the current quarter,\ncompared to a gain of $1.1 million in the prior year quarter. Adjusted other\n(income) expense, net was income of $9.7 million compared to income of $0.2\nmillion in the prior year quarter.\n\nThe effective tax rate for the first nine months of fiscal 2026 was (17.0)%\ncompared to 31.7% in the prior year period. The current year period reflects a\ntax expense on a loss. The fiscal 2026 effective tax rate reflects more\nfavorable discrete and unusual items compared to fiscal 2025. The adjusted\neffective tax rate for the first nine months of fiscal 2026 was 26.3%,\ncompared to 28.8%. from the prior year period.\n\nGAAP net earnings from continuing operations was income of $12.3 million or\n$0.26 per diluted share compared to income of $21.5 million or $0.46 per\ndiluted share in the prior year quarter. Adjusted net earnings from continuing\noperations were $33.5 million or $0.72 per share, inclusive of a $0.04\nfavorable currency impact, compared to $33.6 million or $0.72 per share in the\nprior year quarter. Adjusted EBITDA was $78.9 million, inclusive of a $2.1\nmillion favorable currency impact, compared to $81.2 million in the prior year\nquarter.\n\nNet cash provided by operating activities on a consolidated basis, inclusive\nof continuing and discontinued operations was $47.1 million for the nine\nmonths ended June 30, 2026, compared to $44.3 million in the prior year\nperiod. The increase in cash provided by operating activities was largely\ndriven by changes in net working capital. The third quarter ended with $397.1\nmillion in cash on hand, access to $418.8 million under the Company's U.S.\nrevolving credit facility and an adjusted net debt leverage ratio of 3.7x. The\nadjusted net debt leverage ratio reflects the trailing 12 month continuing\noperations EBITDA as well as the cash impact from temporary working capital\nand other items related to the Feminine Care divestiture.\n\nCapital Allocation\n\nOn August 5, 2026, the Board of Directors declared a quarterly cash dividend\nof $0.15 per common share for the third fiscal quarter of fiscal 2026. The\ndividend will be payable on October 8, 2026 to shareholders of record at the\nclose of business on September 9, 2026.  During the third quarter of fiscal\n2026, the Company paid dividends totaling $7.0 million to stockholders. As of\nJune 30, 2026, the Company had approximately $85 million available for share\nrepurchase in the future under the Board's 2025 authorization.\n\nFiscal 3Q 2026 Operating Segment Results (Unaudited)\n\nWet Shave (Men's Systems, Women's Systems, Disposables, and Shave Preps)\n\nNet sales decreased $4.2 million, or 1.3%. Organic net sales decreased $6.1\nmillion or 1.9%, as growth in the branded business was more than offset by\nlower Private Label sales, related to temporary supply constraints in North\nAmerica and certain international markets. Segment profit decreased $9.2\nmillion, or 20.9%. Organic segment profit, excluding the favorable impact from\ncurrency, decreased $10.9 million, or 24.7%, driven by higher SG&A and\nmarketing expenses.\n\nSun and Skin Care (Sun Care, Men's and Women's Grooming Products, and Wet\nOnes)\n\nNet sales increased $13.9 million, or 5.7%. Organic net sales increased $12.2\nmillion, or 5.0%, driven by mid-single digit growth in Sun Care in North\nAmerica and strong global Grooming and Skin Care performance, partly offset by\nSun Care declines in international markets. Segment profit increased $0.2\nmillion, or 0.4%, including a favorable impact from foreign currency of $0.9\nmillion, or 2.0%. Organic segment profit decreased $0.7 million, or 1.6%,\ndriven by higher marketing and SG&A expenses, partially offset by higher\ngross profit.\n\nFull Fiscal Year 2026 Financial Outlook\n\nThe Company is providing the following outlook assumptions for fiscal 2026.\nUnless otherwise stated, this outlook is presented on a continuing-operations\nbasis and excludes the results of the Feminine Care business, which is\nreported as discontinued operations.\n\nThe Company's underlying expectations for fiscal 2026 remain intact, including\nstronger fourth quarter performance and adjusted EPS and adjusted EBITDA that\nare in line with prior expectations.\n\n * Reported net sales are now expected to increase in the range of approximately\n1.3% to 1.8% (previously increase 0.8% to 3.8%)\n* Includes an estimated 130-basis point positive impact from foreign currency\nchanges (previously 180-basis point positive impact)\n * Organic net sales are expected to be in the range of a flat to 0.5%\n(previously in the range of 1.0% decrease to a 2.0% increase)\n * GAAP EPS is expected to be in the range of flat to $0.20 (previously flat to\n$0.40).\n* Includes: Restructuring and related costs*, Sun Care reformulation, Legal\nmatters, and Other costs\n * Adjusted EPS is expected to be in the range of $1.80 to $2.00 (previously\n$1.70 to $2.10)\n * Adjusted gross margin is expected to increase approximately 20-basis points\n(previously increase 50-basis points). Adjusted operating margin is expected\nto decrease approximately 80-basis points (previously decrease 60-basis\npoints), reflecting 70-basis points from higher A&P investment and\n30-basis points from increased SG&A expense\n * Adjusted EBITDA is expected to be in the range of $250 to $260 million\n(previously $245 to $265 million)\n * Other income/expense, net is expected to be approximately $26 million income,\n(previously $21 million income)\n * Interest expense associated with debt is expected to be approximately $70\nmillion\n * Adjusted effective tax rate is expected to be approximately 22% to 23%\n * Capital expenditures are expected to be in the range of approximately 3.0% to\n3.5% of net sales\n * Adjusted free cash flow is expected to be approximately $80 to $110 million\n * Adjusted net debt leverage is expected to be approximately in the range of\n3.3x to 3.4x at fiscal year end (previously in the range of 3.3x to 3.5x)\nAs previously discussed, in fiscal 2026, the Company is taking specific\nactions to strengthen its operating model, simplify the organization and\nimprove manufacturing and supply chain efficiency through restructuring and\nrepositioning actions, including the further consolidation of Wet Shave\noperations. As a result of these actions, the Company expects to incur pre-tax\ncharges of approximately $92 million (previously $90 million) for the full\nfiscal year.\n\nWebcast Information\n\nIn conjunction with this announcement, the Company will hold an investor\nconference call beginning at 8:00 a.m. Eastern Time today, August 5, 2026.\nAll interested parties may access a live webcast of this conference call at\nwww.edgewell.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745613-1&h=3030866455&u=https%3A%2F%2Fwww.edgewell.com%2F&a=www.edgewell.com)\n, under the \"Investors,\" and \"News and Events\" tabs or by using the following\nlink:  http://ir.edgewell.com/news-and-events/events\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745613-1&h=3657797002&u=http%3A%2F%2Fir.edgewell.com%2Fnews-and-events%2Fevents&a=http%3A%2F%2Fir.edgewell.com%2Fnews-and-events%2Fevents)\n\nRefer to Supplemental Slides for fiscal year 2025 quarterly recast adjusted\nEBITDA reconciliation for continuing operations at www.edgewell.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745613-1&h=3030866455&u=https%3A%2F%2Fwww.edgewell.com%2F&a=www.edgewell.com)\n, under the \"Investors,\" and \"News and Events\" tabs or by using the following\nlink http://ir.edgewell.com/news-and-events/events\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745613-1&h=3657797002&u=http%3A%2F%2Fir.edgewell.com%2Fnews-and-events%2Fevents&a=http%3A%2F%2Fir.edgewell.com%2Fnews-and-events%2Fevents)\n for historical financial information related to Company's divestiture of its\nFeminine Care business consistent with the continuing operations structure.\n\nFor those unable to participate during the live webcast, a re-play will be\navailable on www.edgewell.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745613-1&h=3030866455&u=https%3A%2F%2Fwww.edgewell.com%2F&a=www.edgewell.com)\n, under the \"Investors,\" \"Financial Reports,\" and \"Quarterly Earnings\" tabs.\nThis release includes references to the Company's website and references to\nadditional information and materials found on its website. The Company's\nwebsite and such information and materials are not incorporated by reference\nin, and are not part of, this release.\n\nAbout Edgewell\n\nEdgewell is a leading pure-play consumer products company with an attractive,\ndiversified portfolio of established brand names such as Schick(®), Wilkinson\nSword(® )and Billie(® )men's and women's shaving systems and disposable\nrazors; Edge and Skintimate(® )shave preparations; Banana Boat(®), Hawaiian\nTropic(®), Bulldog(®),  Jack Black(®), and CREMO(®) sun and skin care\nproducts; and Wet Ones(® )products. The Company has a broad global footprint\nand operates in more than 50 markets, including the U.S., Canada, Mexico,\nGermany, Japan, the U.K. and Australia, with approximately 6,200 employees\nworldwide.\n\nForward-Looking Statements. This document contains \"forward-looking\nstatements\" within the meaning of Section 27A of the Securities Act of 1933\nand Section 21E of the Securities Exchange Act of 1934. You should not place\nundue reliance on these statements. These forward-looking statements include,\nbut are not limited to, statements concerning our expectations regarding our\nfuture results of operations and financial condition; including business\ntrajectory and performance improvement; future growth and value creation; our\ncapital allocation plans; impacts from the divestiture of our Feminine Care\nsegment; the effects of macroeconomic factors such as changes in tariffs and\ninflationary pressures; and conflicts or acts of war (such as the conflict in\nthe Middle East). Additional forward-looking statements can generally be\nidentified by the use of words or phrases such as \"believe,\" \"expect,\"\n\"expectation,\" \"anticipate,\" \"may,\" \"could,\" \"intend,\" \"belief,\" \"estimate,\"\n\"plan,\" \"target,\" \"predict,\" \"likely,\" \"will,\" \"should,\" \"forecast,\"\n\"outlook,\" or other similar words or phrases. These statements are not based\non historical facts, but instead reflect the Company's expectations, estimates\nor projections concerning future results or events, including, without\nlimitation, the future earnings and performance of Edgewell or any of its\nbusinesses. Many factors outside our control could affect the realization of\nthese estimates. These statements are not guarantees of performance and are\ninherently subject to known and unknown risks, uncertainties and assumptions\nthat are difficult to predict and could cause the Company's actual results to\ndiffer materially from those indicated by those statements. The Company cannot\nassure you that any of its expectations, estimates or projections will be\nachieved. The forward-looking statements included in this document are only\nmade as of the date of this document and the Company disclaims any obligation\nto publicly update any forward-looking statement to reflect subsequent events\nor circumstances, except as required by law. You should not place undue\nreliance on these statements.\n\nFactors that could cause fluctuations in our actual results include, but are\nnot limited to, the following: our ability to compete in products and prices,\nas well as costs, in an intensely competitive industry; the loss of any of our\nprincipal customers or changes in the policies of our principal customers; our\ninability to design and execute a successful omnichannel strategy; our ability\nto attract, retain and develop key personnel; fluctuations in the price and\nsupply of raw materials and costs of labor, warehousing and transportation;\nthe impact of seasonal volatility on our sales, financial performance, working\ncapital requirements and cash flow; the ability to successfully manage\nevolving global financial risks, including tariffs, foreign currency\nfluctuations, currency exchange or pricing controls and localized volatility;\nthe ability to manage disruption of business due to various factors, including\nones outside of our control, such as natural disasters, conflicts or acts of\nwar (such as the conflict in the Middle East), terrorism or disease outbreaks;\nimpacts from any loss of our principal customers or changes in the policies or\nstrategies of our customers; our level of indebtedness and the various\ncovenants related thereto, and to generate sufficient income and cash flow to\nallow the Company to effect expected share repurchases and dividend payments;\nour failure to maintain our brands' reputation and successfully respond to\nchanging consumer habits; and perceptions of certain ingredients, negative\nperceptions of packaging, lack of recyclability or other environmental\nattributes; our access to capital markets and borrowing capacity; impairment\nof our goodwill and other intangible assets; the ability to successfully\nmanage the financial, legal, reputational and operational risks associated\nwith third-party relationships, such as our suppliers, contract manufacturers,\ndistributors, contractors and external business partners; risks associated\nwith our international operations; our ability to effectively integrate\nacquired companies and successfully manage divestiture activities; our ability\nto successfully implement our cost savings initiatives, including\nrationalization or restructuring efforts; the ability to rely on and maintain\nkey Company and third-party information and operational technology systems,\nnetworks and services and maintain the security and functionality of such\nsystems, networks and services and the data contained therein; the ability to\nsuccessfully achieve, maintain or adjust our environmental or sustainability\ngoals and priorities; the ability to successfully manage current and expanding\nregulatory and legal requirements and matters (including, without limitation,\nthose laws and regulations involving product liability, product and packaging\ncomposition, manufacturing processes, intellectual property, labor and\nemployment, antitrust, privacy, cybersecurity and data protection, artificial\nintelligence, tax, the environment, due diligence, risk oversight, accounting\nand financial reporting) and to resolve new and pending matters within current\nestimates; the ability to adequately protect our intellectual property rights;\nproduct quality and safety issues, including recalls and product liability;\n losses or increased funding and expenses related to our pension plans; and\nthe other important factors described in our Annual Report on Form 10-K for\nthe fiscal year ended September 30, 2025 (\"2025 Annual Report\") under Part I.\nItem 1A. \"Risk Factors,\" and in our other filings with the Securities and\nExchange Commission (\"SEC\"). In addition, other risks and uncertainties not\npresently known to the Company or that it presently considers immaterial could\nsignificantly affect the accuracy of any such forward-looking statements.\nRisks and uncertainties include those detailed from time to time in the\nCompany's publicly filed documents, including in Item 1A. Risk Factors of Part\nI of the Company's Annual Report on Form 10-K filed with the Securities and\nExchange Commission (the \"SEC\") on November 18, 2025.\n\nNon-GAAP Financial Measures. While the Company reports financial results in\naccordance with generally accepted accounting principles (\"GAAP\") in the U.S.,\nthis discussion also includes non-GAAP measures. These non-GAAP measures are\nreferred to as \"adjusted\" or \"organic\" and exclude items which are considered\nby the Company as unusual or non-recurring and which\n\nmay have a disproportionate positive or negative impact on the Company's\nfinancial results in any particular period. Reconciliations of non-GAAP\nmeasures, including reconciliations of measures related to the Company's\nfiscal 2026 financial outlook, are included within the Notes to Condensed\nConsolidated Financial Statements included with this release.\n\nThis non-GAAP information is provided as a supplement to, not as a substitute\nfor, or as superior to, measures of financial performance prepared in\naccordance with GAAP. The Company uses this non-GAAP information internally to\nmake operating decisions and believes it is helpful to investors because it\nallows more meaningful period-to-period comparisons of ongoing operating\nresults. The information can also be used to perform analysis and to better\nidentify operating trends that may otherwise be masked or distorted by the\ntypes of items that are excluded. This non-GAAP information is a component in\ndetermining management's incentive compensation. Finally, the Company believes\nthis information provides a higher degree of transparency. The following\nprovides additional detail on the Company's non-GAAP measures:\n\n * The Company utilizes \"adjusted\" non-GAAP measures including gross margin,\nSG&A, operating income, operating margin, effective tax rate, net\nearnings, earnings per share, EBITDA, and other (income) expense to internally\nmake operating decisions.\n* Constant currency measures are calculated by removing the impact of\ntranslational and transactional foreign currencies changes, net of foreign\ncurrency hedges compared to the prior year. Transactional foreign currency\nchanges are driven by foreign legal entities' transactions not denominated in\nlocal currency.\n * The Company analyzes its net sales and segment profit on an organic basis to\nbetter measure the comparability of results between periods. Organic net sales\nand organic segment profit exclude the impact of changes in foreign currency.\n* Segment profit is impacted by fluctuations in translation and transactional\nforeign currency. The impact of currency was applied to segments using\nmanagement's best estimate.\n * The Company presents certain metrics on a consolidated and continuing\noperations basis to help with comparability.\n * Free cash flow is defined as net cash from operating activities, less capital\nexpenditures plus collections of deferred purchase price of accounts\nreceivable sold and proceeds from sales of fixed assets. Adjusted free cash\nflow is defined as free cash flow, adjusted for the following: the one-time\noperating cash flow impacts associated directly with Feminine Care divestiture\nincluding tax, working capital, and deal related fees and expenses.\n * Net debt is defined as Gross debt less cash and cash equivalents. Net debt\nleverage ratio is defined as net debt divided by trailing twelve month\nadjusted EBITDA. Adjusted net debt leverage ratio is defined as net debt\ndivided by continuing operations trailing twelve month adjusted EBITDA, which\nincludes Transition Services Agreement income realized in fiscal Q2 and Q3\n(five months), plus $15 million of pro forma Transition Services Agreement\nincome (seven months). Refer to Supplemental Slides for fiscal year 2025\nquarterly recast adjusted EBITDA reconciliation for continuing operations\nfiled on February 9, 2026.\nBasis of Presentation. In accordance with applicable accounting guidance, the\nresults of the Feminine Care segment are presented as discontinued operations\nin the Condensed Consolidated Statements of Earnings and Comprehensive Income\nand, as such, have been excluded from both continuing operations and segment\nresults for all periods presented. Further, the Company reclassified the\nassets and liabilities of the Feminine Care disposal group as assets and\nliabilities held for sale in the Condensed Consolidated Balance Sheet as of\nSeptember 30, 2025. The Condensed Consolidated Statements of Cash Flows are\npresented on a consolidated basis with both continuing operations and\ndiscontinued operations. All amounts, percentages and disclosures for all\nperiods presented reflect only the continuing operations of Edgewell unless\notherwise noted.\n\nPlease refer to the Form 10-Q filed with the SEC on August 5, 2026.\n EDGEWELL PERSONAL CARE COMPANY\n\nCONDENSED CONSOLIDATED STATEMENTS OF EARNINGS\n\n(unaudited, in millions, except per share data)\n\n                                                                 Three Months Ended                                                   Nine Months Ended\n\nJune 30,\nJune 30,\n                                                                 2026                                  2025                           2026                                 2025\n Net sales                                                       $         570.1                       $         560.4                $       1,512.4                      $       1,492.1\n Cost of products sold                                           327.6                                 310.3                          892.0                                832.7\n Gross profit                                                    242.5                                 250.1                          620.4                                659.4\n\n Selling, general and administrative expense                     108.3                                 100.7                          321.7                                303.1\n Advertising and sales promotion expense                         83.2                                  76.0                           187.4                                182.0\n Research and development expense                                13.3                                  13.5                           42.0                                 40.2\n Restructuring charges                                           12.7                                  14.9                           44.8                                 30.9\n Operating income                                                25.0                                  45.0                           24.5                                 103.2\n Interest expense associated with debt                           16.7                                  19.4                           53.9                                 58.4\n Other income, net                                               (9.7)                                 (2.9)                          (18.4)                               (2.3)\n Earnings (loss) from continuing operations before income taxes  18.0                                  28.5                           (11.0)                               47.1\n Income tax provision on continuing operations                   5.7                                   7.0                            1.9                                  15.0\n Net earnings (loss) from continuing operations                  12.3                                  21.5                           (12.9)                               32.1\n Earnings (loss) from discontinued operations, net of tax        1.4                                   7.6                            (49.7)                               23.9\n Net earnings (loss)                                             $           13.7                      $           29.1               $          (62.6)                    $           56.0\n\n Basic earnings (loss) per share\n Continuing operations                                           $           0.27                      $           0.46               $          (0.28)                    $           0.67\n Discontinued operations                                         0.03                                  0.16                           (1.07)                               0.50\n Basic earnings (loss) per share                                 $           0.30                      $           0.62               $          (1.35)                    $           1.17\n\n Diluted earnings (loss) per share\n Continuing operations                                           $           0.26                      $           0.46               $          (0.28)                    $           0.67\n Discontinued operations                                         0.03                                  0.16                           (1.07)                               0.50\n Diluted earnings (loss) per share                               $           0.29                      $           0.62               $          (1.35)                    $           1.17\n\n Weighted-average shares outstanding:\n Basic                                                           46.1                                  46.8                           46.4                                 47.8\n Diluted                                                         46.6                                  47.0                           46.4                                 48.0\n\nSee Accompanying Notes.\n\n \n EDGEWELL PERSONAL CARE COMPANY\n\nCONDENSED CONSOLIDATED BALANCE SHEETS\n\n(unaudited, in millions)\n\n                                                          June 30, 2026                  September 30,\n                                                                                         2025\n Assets\n Current assets\n Cash and cash equivalents                                $         397.1                $         225.7\n Trade receivables, less allowance for doubtful accounts  119.4                          137.8\n Inventories                                              433.0                          433.8\n Other current assets                                     162.5                          138.6\n Current assets held for sale                             —                              59.6\n Total current assets                                     1,112.0                        995.5\n Property, plant and equipment, net                       292.7                          295.0\n Goodwill                                                 1,134.0                        1,137.1\n Other intangible assets, net                             806.4                          828.2\n Other assets                                             190.3                          178.7\n Non-current assets held for sale                         —                              321.8\n Total assets                                             $       3,535.4                $       3,756.3\n\n Liabilities and Shareholders' Equity\n Current liabilities\n Notes payable                                            $           34.2               $           29.5\n Accounts payable                                         230.7                          219.7\n Other current liabilities                                338.7                          311.1\n Current liabilities held for sale                        —                              5.2\n Total current liabilities                                603.6                          565.5\n Long-term debt                                           1,245.0                        1,383.3\n Deferred income tax liabilities                          79.6                           118.8\n Other liabilities                                        147.3                          135.6\n Total liabilities                                        2,075.5                        2,203.2\n\n Shareholders' equity\n Common shares                                            0.7                            0.7\n Additional paid-in capital                               1,569.7                        1,578.8\n Retained earnings                                        1,002.1                        1,086.7\n Common shares in treasury at cost                        (997.5)                        (1,003.3)\n Accumulated other comprehensive loss                     (115.1)                        (109.8)\n Total shareholders' equity                               1,459.9                        1,553.1\n Total liabilities and shareholders' equity               $       3,535.4                $       3,756.3\n\nSee Accompanying Notes.\n\n \n EDGEWELL PERSONAL CARE COMPANY\n\nCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS\n\n(unaudited, in millions)\n\n                                                                             Nine Months Ended\n\nJune 30,\n                                                                             2026                                     2025\n Cash Flow from Operating Activities\n Net (loss) earnings                                                         $            (62.6)                      $              56.0\n Depreciation and amortization                                               59.0                                     65.6\n Share-based compensation expense                                            14.7                                     18.8\n Loss on sale of assets                                                      1.4                                      1.7\n Impairment charges                                                          37.4                                     —\n Loss on assets held for sale                                                2.2                                      —\n Deferred compensation payments                                              (2.3)                                    (2.4)\n Deferred income taxes                                                       (39.8)                                   (0.5)\n Other, net                                                                  8.3                                      (12.2)\n Changes in operating assets and liabilities                                 28.8                                     (82.7)\n Net cash provided by operating activities                                   47.1                                     44.3\n\n Cash Flow from Investing Activities\n Proceeds from sale of business                                              338.9                                    —\n Capital expenditures                                                        (41.2)                                   (49.4)\n Collection of deferred purchase price on accounts receivable sold           3.3                                      5.6\n Other, net                                                                  —                                        (1.5)\n Net cash provided by (used in) investing activities                         301.0                                    (45.3)\n\n Cash Flow from Financing Activities\n Cash proceeds from debt with original maturities greater than 90 days       398.0                                    774.0\n Cash payments on debt with original maturities greater than 90 days         (538.0)                                  (678.0)\n Net proceeds from (payment of) debt with original maturities of 90 days or  3.1                                      (0.8)\n less\n Repurchase of shares                                                        (15.8)                                   (90.2)\n Dividends to common shareholders                                            (21.5)                                   (22.4)\n Employee shares withheld for taxes                                          (2.9)                                    (7.4)\n Net financing inflow from the Accounts Receivable Facility                  2.7                                      14.2\n Other, net                                                                  (0.3)                                    (0.3)\n Net cash used in financing activities                                       (174.7)                                  (10.9)\n\n Effect of exchange rate changes on cash                                     (2.0)                                    2.4\n\n Net increase (decrease) in cash and cash equivalents                        171.4                                    (9.5)\n Cash and cash equivalents, beginning of period                              225.7                                    209.1\n Cash and cash equivalents, end of period                                    $            397.1                       $            199.6\n\nSee Accompanying Notes.\n\nEDGEWELL PERSONAL CARE COMPANY\nNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS\n(unaudited, in millions, except per share data)\n\nNote 1 —  Segments\n\nThe Company conducts its business in the following two segments: Wet Shave and\nSun and Skin Care (collectively, the \"Segments,\" and each individually, a\n\"Segment\"). Segment performance is evaluated based on segment profit,\nexclusive of general corporate expenses, share-based compensation costs, items\nwhich are considered by the Company to be unusual or non-recurring and which\nmay have a disproportionate positive or negative impact on the Company's\nfinancial results in any particular period and the amortization of intangible\nassets. Financial items, such as interest income and expense, are managed on a\nglobal basis at the corporate level. The exclusion of such charges from\nsegment results reflects management's view on how it evaluates segment\nperformance.\n\nSegment net sales and profitability are presented below:\n                                            Three Months Ended                                           Nine Months Ended\n                                            June 30,                                                     June 30,\n                                            2026                              2025                       2026                         2025\n Net sales\n Wet Shave                                  $        312.8                    $        317.0             $       898.2                $         897.0\n Sun and Skin Care                          257.3                             243.4                      614.2                        595.1\n Total net sales                            $        570.1                    $        560.4             $    1,512.4                 $      1,492.1\n\n Segment Profit\n Wet Shave                                  $          34.9                   $          44.1            $       106.0                $         137.3\n Sun and Skin Care                          46.2                              46.0                       89.5                         93.4\n Total segment profit                       81.1                              90.1                       195.5                        230.7\n\n General corporate and other expenses       (21.9)                            (19.9)                     (66.0)                       (65.9)\n Amortization of intangibles                (6.2)                             (6.4)                      (19.0)                       (19.2)\n Interest and other expense, net            (7.0)                             (19.3)                     (37.7)                       (58.6)\n Restructuring and related costs            (24.5)                            (16.8)                     (71.9)                       (32.7)\n Acquisition and integration costs          —                                 —                          —                            (0.5)\n Sun Care reformulation costs               (0.7)                             (0.5)                      (3.4)                        (2.2)\n Legal matters                              —                                 —                          (5.7)                        —\n Gain on investment                         —                                 —                          1.5                          0.9\n Commercial realignment                     0.2                               0.1                        0.2                          (3.0)\n Other project and related costs            (3.0)                             1.2                        (4.5)                        (2.4)\n Total earnings (loss) before income taxes  $         18.0                    $         28.5             $      (11.0)                $         47.1\n\n Refer to Note 2 - GAAP to Non-GAAP Reconciliations below for the income\n statement location of non-GAAP adjustments to earnings before income taxes.\n\nNote 2 — GAAP to Non-GAAP Reconciliations\n\nThe following tables provide a GAAP to Non-GAAP reconciliation of certain line\nitems from the Condensed Consolidated Statement of Earnings:\n Three Months Ended June 30, 2026\n                                                  Gross Profit      SG&A              Operating            EBIT (Loss)                      Income Tax                      Net (Loss)             Diluted EPS\n                                                                                      Income               from                             Provision                       Income from            from\n                                                                                                           Continuing                       (Benefit)                       Continuing             Continuing\n                                                                                                           Operations( (1))                 from                            Operations             Operations\n                                                                                                                                            Continuing\n                                                                                                                                            Operations\n GAAP — Reported                                  $    242.5        $    108.3        $      25.0          $       18.0                     $        5.7                    $       12.3           $      0.26\n Restructuring and related costs                  11.2              (0.6)             24.5                 24.5                             6.0                             18.5                   0.40\n Sun Care reformulation costs                     —                 —                 0.7                  0.7                              0.1                             0.6                    0.01\n Commercial realignment                           (0.2)             —                 (0.2)                (0.2)                            (0.1)                           (0.1)                  —\n Other project and related costs                  0.1               (2.9)             3.0                  3.0                              0.8                             2.2                    0.05\n Total Adjusted Non-GAAP                          $    253.6        $    104.8        $      53.0          $       46.0                     $       12.5                    $       33.5           $      0.72\n\n                                                                                                           Adjusted Non-GAAP Constant Currency                                                     0.68\n\n GAAP as a percent of net sales                   42.5 %            19.0 %            4.4 %                GAAP effective tax rate                                                                 31.5 %\n Adjusted as a percent of net sales               44.5 %            18.4 %            9.3 %                Adjusted effective tax rate                                                             27.2 %\n Adjusted Constant Currency as a percent of net   44.1 %                              8.9 %\n sales\n (1) EBIT is defined as Earnings before Income taxes.\n\n \n Three Months Ended June 30, 2025\n                                     Gross Profit      SG&A               Operating          EBIT (Loss)                      Income Tax              Net (Loss)             Diluted EPS\n                                                                          Income             from                             Provision               Income from            from\n                                                                                             Continuing                       (Benefit)               Continuing             Continuing\n                                                                                             Operations( (1))                 from                    Operations             Operations\n                                                                                                                              Continuing\n                                                                                                                              Operations\n GAAP — Reported                     $    250.1        $    100.7         $     45.0         $       28.5                     $        7.0            $       21.5           $     0.46\n Restructuring and related costs     1.2               (0.6)              16.7               16.7                             4.1                     12.6                   0.27\n Sun Care reformulation costs        —                 —                  0.5                0.5                              0.1                     0.4                    0.01\n Commercial realignment              (0.1)             —                  (0.1)              (0.1)                            —                       (0.1)                  —\n Other project and related costs     —                 (1.5)              1.5                (1.2)                            (0.4)                   (0.8)                  (0.02)\n Total Adjusted Non-GAAP             $    251.2        $     98.6         $     63.6         $       44.4                     $       10.8            $       33.6           $     0.72\n\n GAAP as a percent of net sales      44.6 %            18.0 %             8.0 %              GAAP effective tax rate                                                         24.5 %\n Adjusted as a percent of net sales  44.8 %            17.6 %             11.3 %             Adjusted effective tax rate                                                     24.3 %\n (1) EBIT is defined as Earnings before Income taxes.\n\n \n Nine Months Ended June 30, 2026\n                                                  Gross Profit      SG&A              Operating            EBIT (Loss)                      Income Tax                      Net (Loss)             Diluted EPS\n                                                                                      Income               from                             Provision                       Income from            from\n                                                                                                           Continuing                       (Benefit)                       Continuing             Continuing\n                                                                                                           Operations( (1))                 from                            Operations             Operations\n                                                                                                                                            Continuing\n                                                                                                                                            Operations\n GAAP — Reported                                  $    620.4        $    321.7        $      24.5          $      (11.0)                    $        1.9                    $      (12.9)          $     (0.28)\n Restructuring and related costs                  25.7              (1.4)             71.9                 71.9                             17.7                            54.2                   1.17\n Sun Care reformulation costs                     —                 —                 3.4                  3.4                              0.8                             2.6                    0.06\n Legal matters                                    —                 (5.7)             5.7                  5.7                              1.4                             4.3                    0.09\n Gain on investment                               —                 —                 —                    (1.5)                            (0.3)                           (1.2)                  (0.03)\n Commercial realignment                           (0.2)             —                 (0.2)                (0.2)                            (0.1)                           (0.1)                  —\n Other project and related costs                  0.1               (5.1)             5.2                  4.5                              1.1                             3.4                    0.07\n Tax shortfall on equity compensation             —                 —                 —                    —                                (3.4)                           3.4                    0.07\n Total Adjusted Non-GAAP                          $    646.0        $    309.5        $    110.5           $       72.8                     $       19.1                    $       53.7           $      1.15\n\n                                                                                                           Adjusted Non-GAAP Constant Currency                                                     1.07\n\n GAAP as a percent of net sales                   41.0 %            21.3 %            1.6 %                GAAP effective tax rate                                                                 (17.0) %\n Adjusted as a percent of net sales               42.7 %            20.5 %            7.3 %                Adjusted effective tax rate                                                             26.3 %\n Adjusted Constant Currency as a percent of net   42.5 %                              6.9 %\n sales\n (1) EBIT is defined as Earnings (Loss) before Income taxes.\n\n \n Nine Months Ended June 30, 2025\n                                     Gross Profit      SG&A              Operating         EBIT (Loss)                      Income Tax             Net (Loss)             Diluted EPS\n                                                                         Income            from                             Provision              Income                 from\n                                                                                           Continuing                       (Benefit)              from                   Continuing\n                                                                                           Operations( (1))                 from                   Continuing             Operations\n                                                                                                                            Continuing             Operations\n                                                                                                                            Operations\n GAAP — Reported                     $    659.4        $    303.1        $    103.2        $       47.1                     $       15.0           $       32.1           $     0.67\n Restructuring and related costs     1.2               (0.6)             32.7              32.7                             8.0                    24.7                   0.50\n Acquisition and integration costs   —                 (0.5)             0.5               0.5                              0.1                    0.4                    0.01\n Sun Care reformulation costs        —                 —                 2.2               2.2                              0.5                    1.7                    0.04\n Gain on investment                  —                 —                 —                 (0.9)                            —                      (0.9)                  (0.02)\n Commercial realignment              3.0               —                 3.0               3.0                              0.9                    2.1                    0.04\n Other project and related costs     —                 (3.9)             3.9               2.4                              0.6                    1.8                    0.04\n Total Adjusted Non-GAAP             $    663.6        $    298.1        $    145.5        $       87.0                     $       25.1           $       61.9           $     1.28\n\n GAAP as a percent of net sales      44.2 %            20.3 %            6.9 %             GAAP effective tax rate                                                        31.7 %\n Adjusted as a percent of net sales  44.5 %            20.0 %            9.8 %             Adjusted effective tax rate                                                    28.8 %\n (1) EBIT is defined as Earnings before Income taxes.\n\nNote 3 - Net Sales and Profit (Loss) by Segment\n\nOperations for the Company are reported via two segments. The following tables\npresent changes in net sales and segment profit for the three and nine months\nended June 30, 2026, as compared to the corresponding period in the prior year\nquarter.\n Net Sales\n Quarter Ended June 30, 2026      Wet Shave                                 Sun and Skin Care                          Total\n Net sales -  Q3 2025             $      317.0                              $      243.4                               $      560.4\n Organic                          (6.1)                        (1.9) %      12.2                           5.0 %       6.1                        1.1 %\n Impact of currency               1.9                          0.6 %        1.7                            0.7 %       3.6                        0.6 %\n Net sales -  Q3 2026             $      312.8                 (1.3) %      $      257.3                   5.7 %       $      570.1               1.7 %\n\n Segment Profit\n Quarter Ended June 30, 2026      Wet Shave                                 Sun and Skin Care                          Total\n Segment profit -  Q3 2025        $        44.1                             $        46.0                              $        90.1\n Organic                          (10.9)                       (24.7) %     (0.7)                          (1.6) %     (11.6)                     (12.9) %\n Impact of currency               1.7                          3.8 %        0.9                            2.0 %       2.6                        2.9 %\n Segment profit -  Q3 2026        $        34.9                (20.9) %     $        46.2                  0.4 %       $        81.1              (10.0) %\n\n Net Sales\n Nine Months Ended June 30, 2026  Wet Shave                                 Sun and Skin Care                          Total\n Net sales -  Q3 2025             $      897.0                              $      595.1                               $    1,492.1\n Organic                          (19.8)                       (2.2) %      11.4                           1.9 %       (8.4)                      (0.6) %\n Impact of currency               21.0                         2.3 %        7.7                            1.3 %       28.7                       2.0 %\n Net sales -  Q3 2026             $      898.2                 0.1 %        $      614.2                   3.2 %       $    1,512.4               1.4 %\n\n Segment Profit\n Nine Months Ended June 30, 2026  Wet Shave                                 Sun and Skin Care                          Total\n Segment profit -  Q3 2025        $      137.3                              $        93.4                              $      230.7\n Organic                          (36.4)                       (26.5) %     (6.3)                          (6.8) %     (42.7)                     (18.5) %\n Impact of currency               5.1                          3.7 %        2.4                            2.6 %       7.5                        3.2 %\n Segment profit -  Q3 2026        $      106.0                 (22.8) %     $        89.5                  (4.2) %     $      195.5               (15.3) %\n\n For all tables, the impact of currency to segment profit includes both the\n translational and transactional currency changes during the quarter.\n\nNote 4 - Net Debt and EBITDA\n\nThe Company reports financial results on a GAAP and adjusted basis. The tables\nbelow are used to reconcile Net Debt and Net earnings to EBITDA and Adjusted\nEBITDA, which are non-GAAP measures, to improve comparability of results\nbetween periods.\n                                  June 30,                     September 30,\n                                  2026                         2025\n Notes payable                    $          34.2              $           29.5\n Long-term debt                   1,245.0                      1,383.3\n Gross debt                       1,279.2                      1,412.8\n Less: Cash and cash equivalents  397.1                        225.7\n Net debt                         $         882.1              $       1,187.1\n\n \n                                        Three Months Ended                                                   Nine Months Ended\n\nJune 30,\nJune 30,\n                                        2026                                  2025                           2026                                 2025\n Net Earnings                           $           12.3                      $           21.5               $          (12.9)                    $           32.1\n Income tax provision                   5.7                                   7.0                            1.9                                  15.0\n Interest expense, net                  14.8                                  19.0                           50.7                                 56.9\n Depreciation and amortization          18.6                                  18.3                           57.7                                 54.0\n EBITDA                                 51.4                                  65.7                           97.4                                 158.0\n\n Restructuring and related costs( (1))  24.0                                  16.3                           68.4                                 31.5\n Acquisition and integration costs      —                                     —                              —                                    0.5\n Sun Care reformulation costs           0.7                                   0.5                            3.4                                  2.2\n Legal matters                          —                                     —                              5.7                                  —\n (Gain) loss on investment              —                                     —                              (1.5)                                (0.9)\n Commercial realignment                 (0.2)                                 (0.1)                          (0.2)                                3.0\n Other project and related costs        3.0                                   (1.2)                          4.5                                  2.4\n Adjusted EBITDA                        $           78.9                      $           81.2               $          177.7                     $          196.7\n\n   (1)  Excludes $0.5 million and $3.5 million of accelerated depreciation, which is\n        included within Depreciation and amortization during the three and nine months\n        ended June 30, 2026, respectively and $0.6 million and $1.2 million during the\n        three and nine months ended June 30, 2025, respectively.\n\nNote 5 - Outlook for Continuing Operations\n\nThe following tables provide reconciliations of Adjusted EPS and Adjusted\nEBITDA, Non-GAAP measures, included within the Company's projected fiscal 2026\noutlook for continuing operations. The below outlook reflects management's\napproximate expectations and are subject to rounding adjustments. As a result,\nthe sum of individual amounts may not precisely equal the totals presented.\n Adjusted EPS Outlook\n Fiscal 2026 GAAP EPS                         approx.  $0.00 - $0.20\n\n Restructuring and related costs              approx.  1.96\n Sun Care reformulation costs                 approx.  0.11\n Legal Matter                                 approx.  0.12\n Gain on Investment                           approx.  (0.03)\n Other costs                                  approx.  0.13\n Income taxes((1))                            approx.  (0.49)\n\n Fiscal 2026 Adjusted EPS Outlook (Non-GAAP)  approx.  $1.80 - $2.00\n\n (1)     Income tax effect of the adjustments to Fiscal 2026 GAAP EPS noted above.\n\n \n Adjusted EBITDA Outlook\n Fiscal 2026 GAAP Net Income                  approx.  $0 - $10\n Income tax provision                         approx.  4\n Interest expense, net of $5 interest income  approx.  65\n Depreciation and amortization                approx.  77\n EBITDA                                       approx.  $146 - $156\n\n Restructuring and related costs( (2))        approx.  88\n Sun Care reformulation costs                 approx.  5\n Legal Matter                                 approx.  6\n Gain on Investment                           approx.  (1)\n Other costs                                  approx.  6\n Fiscal 2026 Adjusted EBITDA                  approx.  $250 - $260\n\n ((2))     Excludes accelerated depreciation, which is included within Depreciation and\n           amortization.\n\n \n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-third-quarter-fiscal-2026-results-302843031.html\n(https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-third-quarter-fiscal-2026-results-302843031.html)\n\nSOURCE Edgewell Personal Care Company\n\n\n\nCompany Contact: Chris Gough, Vice President, Investor Relations, 203-944-5706, Chris.Gough@Edgewell.com\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS384772/Edgewell-v1-Logo.jpg?id=OA2824444\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn4L5Gp1a","title":"Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results","author":"PR Newswire","ticker":"EPC","created":"2026-08-05T10:00:00.750Z","tickers":["EPC"],"exchange":"NYSE","article_body":"Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results\n\nPR Newswire\n\nSHELTON, Conn., Aug. 5, 2026\n\nOrganic Net Sales Returned to Growth; North America Performance Improved\nMeaningfully\n\nAdjusted EPS and Adjusted EBITDA Exceeded Expectations\n\nFull Year Outlook Narrowed; Mid-points for Adjusted EPS and Adjusted EBITDA\nRemain Unchanged\n\nSHELTON, Conn., Aug. 5, 2026 /PRNewswire/ -- Edgewell Personal Care Company\n(NYSE: EPC) today announced results for its third fiscal quarter 2026 ended\nJune 30, 2026.\n\nExecutive Summary\n\n * Third quarter net sales were $570.1 million, an increase of 1.7% compared to\nthe prior year quarter.\n * Organic net sales increased 1.1%. (Organic basis excludes the impact from\ncurrency movements.)\n * GAAP Diluted net Earnings Per Share (\"EPS\") were $0.26, compared to $0.46 in\nthe prior year quarter.\n * Adjusted EPS were $0.72 for the quarter, compared to $0.72 in the prior year\nquarter.\n * Ended the third quarter with $397.1 million in cash on hand, access to an\nadditional $418.8 million under the Company's U.S. revolving credit facility\navailable.\n * Returned $7.0 million to shareholders in the form of dividends in the third\nquarter.\n * The Board of Directors declared a cash dividend of $0.15 per common share on\nAugust 5, 2026, for the third quarter.\n\"Our third quarter results represent an important step forward in our fiscal\n2026 progression, with organic net sales returning to growth, meaningful\nimprovement in North America, and adjusted EPS and adjusted EBITDA ahead of\nexpectations,\" said Rod Little, Edgewell's President and Chief Executive\nOfficer. \"At the beginning of the year, we anticipated that fiscal 2026 would\nbe a back-half story, and based on our current outlook, we remain on track to\ndeliver on that commitment. Our priority brands continue to gain traction, and\nwe believe that the investments we have made are strengthening our\ncapabilities and improving business performance. We are increasingly confident\nin the trajectory of the business and the foundation we are building for\nfuture growth and value creation.\"\n\nUnless otherwise noted, reported results in this release are based on\ncontinuing operations and exclude the Feminine Care business which is treated\nas discontinued operations. The Company reports and forecasts results on a\nGAAP and non-GAAP basis and has reconciled non-GAAP results and outlook to the\nmost directly comparable GAAP measures later in this release. See non-GAAP\nFinancial Measures for a more detailed explanation, including definitions of\nvarious non-GAAP terms used in this release. All comparisons used in this\nrelease are for the same period in the prior fiscal year unless otherwise\nstated.\n\nFiscal 3Q 2026 Operating Results (Unaudited)\n\nNet sales were $570.1 million in the quarter, an increase of $9.7 million, or\n1.7%, including a $3.6 million, or 0.6% favorable impact from currency\nmovements. Organic net sales increased $6.1 million, or 1.1%, reflecting a\nreturn to growth in North America, partially offset by lower sales in\ninternational markets. North America organic sales increased 3.0%, driven by\nvolume growth across Sun, Skin Care and Grooming, reflecting improving\nexecution, increased distribution and continued strength across several of the\nCompany's priority brands. International organic sales declined 1.4%,\nprimarily reflecting temporary disruption associated with the conflict in the\nMiddle East and short-term supply chain impacts related to the Company's Wet\nShave manufacturing consolidation, partially offset by growth in Grooming and\nseveral key international markets.\n\nGross profit was $242.5 million, as compared to $250.1 million in the prior\nyear quarter. Gross margin as a percent of net sales was 42.5%,a decrease of\n210-basis points. Adjusted gross margin as a percent of net sales decreased\n30-basis points, to 44.5% in the quarter. Productivity savings of\napproximately 200-basis points and 40-basis points of favorable currency\nmovements were more than offset by 160-basis points of core inflation and net\ntariffs and 110-basis points of unfavorable mix and promotional levels (net of\npricing).\n\nAdvertising and sales promotion expense (\"A&P\") was $83.2 million, or\n14.6% of net sales, an increase of $7.2 million, compared to $76.0 million, or\n13.6% of net sales in the prior year quarter.\n\nSelling, general and administrative expense (\"SG&A\") was $108.3 million,\nor 19.0% of net sales, as compared to $100.7 million, or 18.0% of net sales in\nthe prior year quarter. Adjusted SG&A was 18.4% of net sales, compared to\n17.6% in the prior year quarter which was primarily driven by higher incentive\ncompensation expense and unfavorable currency impacts in the current year,\npartly offset by lower people and consulting expenses.\n\nThe Company recorded pre-tax restructuring and related costs in support of\ncost efficiency and effectiveness programs of $24.5 million in the quarter.\n\nOperating income was $25.0 million, or 4.4% of net sales, inclusive of a $2.6\nmillion, or 40-basis points impact from favorable currency movements, compared\nto income of $45.0 million, or 8.0% of net sales in the prior year quarter.\nAdjusted operating income was $53.0 million, or 9.3% of net sales, compared to\n$63.6 million, or 11.3% of net sales in the prior year quarter.\n\nInterest expense associated with debt was $16.7 million, compared to $19.4\nmillion in the prior year quarter. The decrease in interest expense was the\nresult of lower borrowing levels on the Company's U.S. revolving credit\nfacility due to the paydown of the facility with the proceeds of the Feminine\nCare divestiture.\n\nOther (income) expense, net was income of $9.7 million compared to income of\n$2.9 million in the prior year quarter. The current year quarter included $7.7\nmillion of Transition Services Agreement (\"TSA\") income. Additionally, the\nprior year quarter included $2.7 million of other project gains. Currency\nhedge and remeasurements gains were $0.6 million in the current quarter,\ncompared to a gain of $1.1 million in the prior year quarter. Adjusted other\n(income) expense, net was income of $9.7 million compared to income of $0.2\nmillion in the prior year quarter.\n\nThe effective tax rate for the first nine months of fiscal 2026 was (17.0)%\ncompared to 31.7% in the prior year period. The current year period reflects a\ntax expense on a loss. The fiscal 2026 effective tax rate reflects more\nfavorable discrete and unusual items compared to fiscal 2025. The adjusted\neffective tax rate for the first nine months of fiscal 2026 was 26.3%,\ncompared to 28.8%. from the prior year period.\n\nGAAP net earnings from continuing operations was income of $12.3 million or\n$0.26 per diluted share compared to income of $21.5 million or $0.46 per\ndiluted share in the prior year quarter. Adjusted net earnings from continuing\noperations were $33.5 million or $0.72 per share, inclusive of a $0.04\nfavorable currency impact, compared to $33.6 million or $0.72 per share in the\nprior year quarter. Adjusted EBITDA was $78.9 million, inclusive of a $2.1\nmillion favorable currency impact, compared to $81.2 million in the prior year\nquarter.\n\nNet cash provided by operating activities on a consolidated basis, inclusive\nof continuing and discontinued operations was $47.1 million for the nine\nmonths ended June 30, 2026, compared to $44.3 million in the prior year\nperiod. The increase in cash provided by operating activities was largely\ndriven by changes in net working capital. The third quarter ended with $397.1\nmillion in cash on hand, access to $418.8 million under the Company's U.S.\nrevolving credit facility and an adjusted net debt leverage ratio of 3.7x. The\nadjusted net debt leverage ratio reflects the trailing 12 month continuing\noperations EBITDA as well as the cash impact from temporary working capital\nand other items related to the Feminine Care divestiture.\n\nCapital Allocation\n\nOn August 5, 2026, the Board of Directors declared a quarterly cash dividend\nof $0.15 per common share for the third fiscal quarter of fiscal 2026. The\ndividend will be payable on October 8, 2026 to shareholders of record at the\nclose of business on September 9, 2026.  During the third quarter of fiscal\n2026, the Company paid dividends totaling $7.0 million to stockholders. As of\nJune 30, 2026, the Company had approximately $85 million available for share\nrepurchase in the future under the Board's 2025 authorization.\n\nFiscal 3Q 2026 Operating Segment Results (Unaudited)\n\nWet Shave (Men's Systems, Women's Systems, Disposables, and Shave Preps)\n\nNet sales decreased $4.2 million, or 1.3%. Organic net sales decreased $6.1\nmillion or 1.9%, as growth in the branded business was more than offset by\nlower Private Label sales, related to temporary supply constraints in North\nAmerica and certain international markets. Segment profit decreased $9.2\nmillion, or 20.9%. Organic segment profit, excluding the favorable impact from\ncurrency, decreased $10.9 million, or 24.7%, driven by higher SG&A and\nmarketing expenses.\n\nSun and Skin Care (Sun Care, Men's and Women's Grooming Products, and Wet\nOnes)\n\nNet sales increased $13.9 million, or 5.7%. Organic net sales increased $12.2\nmillion, or 5.0%, driven by mid-single digit growth in Sun Care in North\nAmerica and strong global Grooming and Skin Care performance, partly offset by\nSun Care declines in international markets. Segment profit increased $0.2\nmillion, or 0.4%, including a favorable impact from foreign currency of $0.9\nmillion, or 2.0%. Organic segment profit decreased $0.7 million, or 1.6%,\ndriven by higher marketing and SG&A expenses, partially offset by higher\ngross profit.\n\nFull Fiscal Year 2026 Financial Outlook\n\nThe Company is providing the following outlook assumptions for fiscal 2026.\nUnless otherwise stated, this outlook is presented on a continuing-operations\nbasis and excludes the results of the Feminine Care business, which is\nreported as discontinued operations.\n\nThe Company's underlying expectations for fiscal 2026 remain intact, including\nstronger fourth quarter performance and adjusted EPS and adjusted EBITDA that\nare in line with prior expectations.\n\n * Reported net sales are now expected to increase in the range of approximately\n1.3% to 1.8% (previously increase 0.8% to 3.8%)\n* Includes an estimated 130-basis point positive impact from foreign currency\nchanges (previously 180-basis point positive impact)\n * Organic net sales are expected to be in the range of a flat to 0.5%\n(previously in the range of 1.0% decrease to a 2.0% increase)\n * GAAP EPS is expected to be in the range of flat to $0.20 (previously flat to\n$0.40).\n* Includes: Restructuring and related costs*, Sun Care reformulation, Legal\nmatters, and Other costs\n * Adjusted EPS is expected to be in the range of $1.80 to $2.00 (previously\n$1.70 to $2.10)\n * Adjusted gross margin is expected to increase approximately 20-basis points\n(previously increase 50-basis points). Adjusted operating margin is expected\nto decrease approximately 80-basis points (previously decrease 60-basis\npoints), reflecting 70-basis points from higher A&P investment and\n30-basis points from increased SG&A expense\n * Adjusted EBITDA is expected to be in the range of $250 to $260 million\n(previously $245 to $265 million)\n * Other income/expense, net is expected to be approximately $26 million income,\n(previously $21 million income)\n * Interest expense associated with debt is expected to be approximately $70\nmillion\n * Adjusted effective tax rate is expected to be approximately 22% to 23%\n * Capital expenditures are expected to be in the range of approximately 3.0% to\n3.5% of net sales\n * Adjusted free cash flow is expected to be approximately $80 to $110 million\n * Adjusted net debt leverage is expected to be approximately in the range of\n3.3x to 3.4x at fiscal year end (previously in the range of 3.3x to 3.5x)\nAs previously discussed, in fiscal 2026, the Company is taking specific\nactions to strengthen its operating model, simplify the organization and\nimprove manufacturing and supply chain efficiency through restructuring and\nrepositioning actions, including the further consolidation of Wet Shave\noperations. As a result of these actions, the Company expects to incur pre-tax\ncharges of approximately $92 million (previously $90 million) for the full\nfiscal year.\n\nWebcast Information\n\nIn conjunction with this announcement, the Company will hold an investor\nconference call beginning at 8:00 a.m. Eastern Time today, August 5, 2026.\nAll interested parties may access a live webcast of this conference call at\nwww.edgewell.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745613-1&h=3030866455&u=https%3A%2F%2Fwww.edgewell.com%2F&a=www.edgewell.com)\n, under the \"Investors,\" and \"News and Events\" tabs or by using the following\nlink:  http://ir.edgewell.com/news-and-events/events\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745613-1&h=3657797002&u=http%3A%2F%2Fir.edgewell.com%2Fnews-and-events%2Fevents&a=http%3A%2F%2Fir.edgewell.com%2Fnews-and-events%2Fevents)\n\nRefer to Supplemental Slides for fiscal year 2025 quarterly recast adjusted\nEBITDA reconciliation for continuing operations at www.edgewell.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745613-1&h=3030866455&u=https%3A%2F%2Fwww.edgewell.com%2F&a=www.edgewell.com)\n, under the \"Investors,\" and \"News and Events\" tabs or by using the following\nlink http://ir.edgewell.com/news-and-events/events\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745613-1&h=3657797002&u=http%3A%2F%2Fir.edgewell.com%2Fnews-and-events%2Fevents&a=http%3A%2F%2Fir.edgewell.com%2Fnews-and-events%2Fevents)\n for historical financial information related to Company's divestiture of its\nFeminine Care business consistent with the continuing operations structure.\n\nFor those unable to participate during the live webcast, a re-play will be\navailable on www.edgewell.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745613-1&h=3030866455&u=https%3A%2F%2Fwww.edgewell.com%2F&a=www.edgewell.com)\n, under the \"Investors,\" \"Financial Reports,\" and \"Quarterly Earnings\" tabs.\nThis release includes references to the Company's website and references to\nadditional information and materials found on its website. The Company's\nwebsite and such information and materials are not incorporated by reference\nin, and are not part of, this release.\n\nAbout Edgewell\n\nEdgewell is a leading pure-play consumer products company with an attractive,\ndiversified portfolio of established brand names such as Schick(®), Wilkinson\nSword(® )and Billie(® )men's and women's shaving systems and disposable\nrazors; Edge and Skintimate(® )shave preparations; Banana Boat(®), Hawaiian\nTropic(®), Bulldog(®),  Jack Black(®), and CREMO(®) sun and skin care\nproducts; and Wet Ones(® )products. The Company has a broad global footprint\nand operates in more than 50 markets, including the U.S., Canada, Mexico,\nGermany, Japan, the U.K. and Australia, with approximately 6,200 employees\nworldwide.\n\nForward-Looking Statements. This document contains \"forward-looking\nstatements\" within the meaning of Section 27A of the Securities Act of 1933\nand Section 21E of the Securities Exchange Act of 1934. You should not place\nundue reliance on these statements. These forward-looking statements include,\nbut are not limited to, statements concerning our expectations regarding our\nfuture results of operations and financial condition; including business\ntrajectory and performance improvement; future growth and value creation; our\ncapital allocation plans; impacts from the divestiture of our Feminine Care\nsegment; the effects of macroeconomic factors such as changes in tariffs and\ninflationary pressures; and conflicts or acts of war (such as the conflict in\nthe Middle East). Additional forward-looking statements can generally be\nidentified by the use of words or phrases such as \"believe,\" \"expect,\"\n\"expectation,\" \"anticipate,\" \"may,\" \"could,\" \"intend,\" \"belief,\" \"estimate,\"\n\"plan,\" \"target,\" \"predict,\" \"likely,\" \"will,\" \"should,\" \"forecast,\"\n\"outlook,\" or other similar words or phrases. These statements are not based\non historical facts, but instead reflect the Company's expectations, estimates\nor projections concerning future results or events, including, without\nlimitation, the future earnings and performance of Edgewell or any of its\nbusinesses. Many factors outside our control could affect the realization of\nthese estimates. These statements are not guarantees of performance and are\ninherently subject to known and unknown risks, uncertainties and assumptions\nthat are difficult to predict and could cause the Company's actual results to\ndiffer materially from those indicated by those statements. The Company cannot\nassure you that any of its expectations, estimates or projections will be\nachieved. The forward-looking statements included in this document are only\nmade as of the date of this document and the Company disclaims any obligation\nto publicly update any forward-looking statement to reflect subsequent events\nor circumstances, except as required by law. You should not place undue\nreliance on these statements.\n\nFactors that could cause fluctuations in our actual results include, but are\nnot limited to, the following: our ability to compete in products and prices,\nas well as costs, in an intensely competitive industry; the loss of any of our\nprincipal customers or changes in the policies of our principal customers; our\ninability to design and execute a successful omnichannel strategy; our ability\nto attract, retain and develop key personnel; fluctuations in the price and\nsupply of raw materials and costs of labor, warehousing and transportation;\nthe impact of seasonal volatility on our sales, financial performance, working\ncapital requirements and cash flow; the ability to successfully manage\nevolving global financial risks, including tariffs, foreign currency\nfluctuations, currency exchange or pricing controls and localized volatility;\nthe ability to manage disruption of business due to various factors, including\nones outside of our control, such as natural disasters, conflicts or acts of\nwar (such as the conflict in the Middle East), terrorism or disease outbreaks;\nimpacts from any loss of our principal customers or changes in the policies or\nstrategies of our customers; our level of indebtedness and the various\ncovenants related thereto, and to generate sufficient income and cash flow to\nallow the Company to effect expected share repurchases and dividend payments;\nour failure to maintain our brands' reputation and successfully respond to\nchanging consumer habits; and perceptions of certain ingredients, negative\nperceptions of packaging, lack of recyclability or other environmental\nattributes; our access to capital markets and borrowing capacity; impairment\nof our goodwill and other intangible assets; the ability to successfully\nmanage the financial, legal, reputational and operational risks associated\nwith third-party relationships, such as our suppliers, contract manufacturers,\ndistributors, contractors and external business partners; risks associated\nwith our international operations; our ability to effectively integrate\nacquired companies and successfully manage divestiture activities; our ability\nto successfully implement our cost savings initiatives, including\nrationalization or restructuring efforts; the ability to rely on and maintain\nkey Company and third-party information and operational technology systems,\nnetworks and services and maintain the security and functionality of such\nsystems, networks and services and the data contained therein; the ability to\nsuccessfully achieve, maintain or adjust our environmental or sustainability\ngoals and priorities; the ability to successfully manage current and expanding\nregulatory and legal requirements and matters (including, without limitation,\nthose laws and regulations involving product liability, product and packaging\ncomposition, manufacturing processes, intellectual property, labor and\nemployment, antitrust, privacy, cybersecurity and data protection, artificial\nintelligence, tax, the environment, due diligence, risk oversight, accounting\nand financial reporting) and to resolve new and pending matters within current\nestimates; the ability to adequately protect our intellectual property rights;\nproduct quality and safety issues, including recalls and product liability;\n losses or increased funding and expenses related to our pension plans; and\nthe other important factors described in our Annual Report on Form 10-K for\nthe fiscal year ended September 30, 2025 (\"2025 Annual Report\") under Part I.\nItem 1A. \"Risk Factors,\" and in our other filings with the Securities and\nExchange Commission (\"SEC\"). In addition, other risks and uncertainties not\npresently known to the Company or that it presently considers immaterial could\nsignificantly affect the accuracy of any such forward-looking statements.\nRisks and uncertainties include those detailed from time to time in the\nCompany's publicly filed documents, including in Item 1A. Risk Factors of Part\nI of the Company's Annual Report on Form 10-K filed with the Securities and\nExchange Commission (the \"SEC\") on November 18, 2025.\n\nNon-GAAP Financial Measures. While the Company reports financial results in\naccordance with generally accepted accounting principles (\"GAAP\") in the U.S.,\nthis discussion also includes non-GAAP measures. These non-GAAP measures are\nreferred to as \"adjusted\" or \"organic\" and exclude items which are considered\nby the Company as unusual or non-recurring and which\n\nmay have a disproportionate positive or negative impact on the Company's\nfinancial results in any particular period. Reconciliations of non-GAAP\nmeasures, including reconciliations of measures related to the Company's\nfiscal 2026 financial outlook, are included within the Notes to Condensed\nConsolidated Financial Statements included with this release.\n\nThis non-GAAP information is provided as a supplement to, not as a substitute\nfor, or as superior to, measures of financial performance prepared in\naccordance with GAAP. The Company uses this non-GAAP information internally to\nmake operating decisions and believes it is helpful to investors because it\nallows more meaningful period-to-period comparisons of ongoing operating\nresults. The information can also be used to perform analysis and to better\nidentify operating trends that may otherwise be masked or distorted by the\ntypes of items that are excluded. This non-GAAP information is a component in\ndetermining management's incentive compensation. Finally, the Company believes\nthis information provides a higher degree of transparency. The following\nprovides additional detail on the Company's non-GAAP measures:\n\n * The Company utilizes \"adjusted\" non-GAAP measures including gross margin,\nSG&A, operating income, operating margin, effective tax rate, net\nearnings, earnings per share, EBITDA, and other (income) expense to internally\nmake operating decisions.\n* Constant currency measures are calculated by removing the impact of\ntranslational and transactional foreign currencies changes, net of foreign\ncurrency hedges compared to the prior year. Transactional foreign currency\nchanges are driven by foreign legal entities' transactions not denominated in\nlocal currency.\n * The Company analyzes its net sales and segment profit on an organic basis to\nbetter measure the comparability of results between periods. Organic net sales\nand organic segment profit exclude the impact of changes in foreign currency.\n* Segment profit is impacted by fluctuations in translation and transactional\nforeign currency. The impact of currency was applied to segments using\nmanagement's best estimate.\n * The Company presents certain metrics on a consolidated and continuing\noperations basis to help with comparability.\n * Free cash flow is defined as net cash from operating activities, less capital\nexpenditures plus collections of deferred purchase price of accounts\nreceivable sold and proceeds from sales of fixed assets. Adjusted free cash\nflow is defined as free cash flow, adjusted for the following: the one-time\noperating cash flow impacts associated directly with Feminine Care divestiture\nincluding tax, working capital, and deal related fees and expenses.\n * Net debt is defined as Gross debt less cash and cash equivalents. Net debt\nleverage ratio is defined as net debt divided by trailing twelve month\nadjusted EBITDA. Adjusted net debt leverage ratio is defined as net debt\ndivided by continuing operations trailing twelve month adjusted EBITDA, which\nincludes Transition Services Agreement income realized in fiscal Q2 and Q3\n(five months), plus $15 million of pro forma Transition Services Agreement\nincome (seven months). Refer to Supplemental Slides for fiscal year 2025\nquarterly recast adjusted EBITDA reconciliation for continuing operations\nfiled on February 9, 2026.\nBasis of Presentation. In accordance with applicable accounting guidance, the\nresults of the Feminine Care segment are presented as discontinued operations\nin the Condensed Consolidated Statements of Earnings and Comprehensive Income\nand, as such, have been excluded from both continuing operations and segment\nresults for all periods presented. Further, the Company reclassified the\nassets and liabilities of the Feminine Care disposal group as assets and\nliabilities held for sale in the Condensed Consolidated Balance Sheet as of\nSeptember 30, 2025. The Condensed Consolidated Statements of Cash Flows are\npresented on a consolidated basis with both continuing operations and\ndiscontinued operations. All amounts, percentages and disclosures for all\nperiods presented reflect only the continuing operations of Edgewell unless\notherwise noted.\n\nPlease refer to the Form 10-Q filed with the SEC on August 5, 2026.\n EDGEWELL PERSONAL CARE COMPANY\n\nCONDENSED CONSOLIDATED STATEMENTS OF EARNINGS\n\n(unaudited, in millions, except per share data)\n\n                                                                 Three Months Ended                                                   Nine Months Ended\n\nJune 30,\nJune 30,\n                                                                 2026                                  2025                           2026                                 2025\n Net sales                                                       $         570.1                       $         560.4                $       1,512.4                      $       1,492.1\n Cost of products sold                                           327.6                                 310.3                          892.0                                832.7\n Gross profit                                                    242.5                                 250.1                          620.4                                659.4\n\n Selling, general and administrative expense                     108.3                                 100.7                          321.7                                303.1\n Advertising and sales promotion expense                         83.2                                  76.0                           187.4                                182.0\n Research and development expense                                13.3                                  13.5                           42.0                                 40.2\n Restructuring charges                                           12.7                                  14.9                           44.8                                 30.9\n Operating income                                                25.0                                  45.0                           24.5                                 103.2\n Interest expense associated with debt                           16.7                                  19.4                           53.9                                 58.4\n Other income, net                                               (9.7)                                 (2.9)                          (18.4)                               (2.3)\n Earnings (loss) from continuing operations before income taxes  18.0                                  28.5                           (11.0)                               47.1\n Income tax provision on continuing operations                   5.7                                   7.0                            1.9                                  15.0\n Net earnings (loss) from continuing operations                  12.3                                  21.5                           (12.9)                               32.1\n Earnings (loss) from discontinued operations, net of tax        1.4                                   7.6                            (49.7)                               23.9\n Net earnings (loss)                                             $           13.7                      $           29.1               $          (62.6)                    $           56.0\n\n Basic earnings (loss) per share\n Continuing operations                                           $           0.27                      $           0.46               $          (0.28)                    $           0.67\n Discontinued operations                                         0.03                                  0.16                           (1.07)                               0.50\n Basic earnings (loss) per share                                 $           0.30                      $           0.62               $          (1.35)                    $           1.17\n\n Diluted earnings (loss) per share\n Continuing operations                                           $           0.26                      $           0.46               $          (0.28)                    $           0.67\n Discontinued operations                                         0.03                                  0.16                           (1.07)                               0.50\n Diluted earnings (loss) per share                               $           0.29                      $           0.62               $          (1.35)                    $           1.17\n\n Weighted-average shares outstanding:\n Basic                                                           46.1                                  46.8                           46.4                                 47.8\n Diluted                                                         46.6                                  47.0                           46.4                                 48.0\n\nSee Accompanying Notes.\n\n \n EDGEWELL PERSONAL CARE COMPANY\n\nCONDENSED CONSOLIDATED BALANCE SHEETS\n\n(unaudited, in millions)\n\n                                                          June 30, 2026                  September 30,\n                                                                                         2025\n Assets\n Current assets\n Cash and cash equivalents                                $         397.1                $         225.7\n Trade receivables, less allowance for doubtful accounts  119.4                          137.8\n Inventories                                              433.0                          433.8\n Other current assets                                     162.5                          138.6\n Current assets held for sale                             —                              59.6\n Total current assets                                     1,112.0                        995.5\n Property, plant and equipment, net                       292.7                          295.0\n Goodwill                                                 1,134.0                        1,137.1\n Other intangible assets, net                             806.4                          828.2\n Other assets                                             190.3                          178.7\n Non-current assets held for sale                         —                              321.8\n Total assets                                             $       3,535.4                $       3,756.3\n\n Liabilities and Shareholders' Equity\n Current liabilities\n Notes payable                                            $           34.2               $           29.5\n Accounts payable                                         230.7                          219.7\n Other current liabilities                                338.7                          311.1\n Current liabilities held for sale                        —                              5.2\n Total current liabilities                                603.6                          565.5\n Long-term debt                                           1,245.0                        1,383.3\n Deferred income tax liabilities                          79.6                           118.8\n Other liabilities                                        147.3                          135.6\n Total liabilities                                        2,075.5                        2,203.2\n\n Shareholders' equity\n Common shares                                            0.7                            0.7\n Additional paid-in capital                               1,569.7                        1,578.8\n Retained earnings                                        1,002.1                        1,086.7\n Common shares in treasury at cost                        (997.5)                        (1,003.3)\n Accumulated other comprehensive loss                     (115.1)                        (109.8)\n Total shareholders' equity                               1,459.9                        1,553.1\n Total liabilities and shareholders' equity               $       3,535.4                $       3,756.3\n\nSee Accompanying Notes.\n\n \n EDGEWELL PERSONAL CARE COMPANY\n\nCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS\n\n(unaudited, in millions)\n\n                                                                             Nine Months Ended\n\nJune 30,\n                                                                             2026                                     2025\n Cash Flow from Operating Activities\n Net (loss) earnings                                                         $            (62.6)                      $              56.0\n Depreciation and amortization                                               59.0                                     65.6\n Share-based compensation expense                                            14.7                                     18.8\n Loss on sale of assets                                                      1.4                                      1.7\n Impairment charges                                                          37.4                                     —\n Loss on assets held for sale                                                2.2                                      —\n Deferred compensation payments                                              (2.3)                                    (2.4)\n Deferred income taxes                                                       (39.8)                                   (0.5)\n Other, net                                                                  8.3                                      (12.2)\n Changes in operating assets and liabilities                                 28.8                                     (82.7)\n Net cash provided by operating activities                                   47.1                                     44.3\n\n Cash Flow from Investing Activities\n Proceeds from sale of business                                              338.9                                    —\n Capital expenditures                                                        (41.2)                                   (49.4)\n Collection of deferred purchase price on accounts receivable sold           3.3                                      5.6\n Other, net                                                                  —                                        (1.5)\n Net cash provided by (used in) investing activities                         301.0                                    (45.3)\n\n Cash Flow from Financing Activities\n Cash proceeds from debt with original maturities greater than 90 days       398.0                                    774.0\n Cash payments on debt with original maturities greater than 90 days         (538.0)                                  (678.0)\n Net proceeds from (payment of) debt with original maturities of 90 days or  3.1                                      (0.8)\n less\n Repurchase of shares                                                        (15.8)                                   (90.2)\n Dividends to common shareholders                                            (21.5)                                   (22.4)\n Employee shares withheld for taxes                                          (2.9)                                    (7.4)\n Net financing inflow from the Accounts Receivable Facility                  2.7                                      14.2\n Other, net                                                                  (0.3)                                    (0.3)\n Net cash used in financing activities                                       (174.7)                                  (10.9)\n\n Effect of exchange rate changes on cash                                     (2.0)                                    2.4\n\n Net increase (decrease) in cash and cash equivalents                        171.4                                    (9.5)\n Cash and cash equivalents, beginning of period                              225.7                                    209.1\n Cash and cash equivalents, end of period                                    $            397.1                       $            199.6\n\nSee Accompanying Notes.\n\nEDGEWELL PERSONAL CARE COMPANY\nNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS\n(unaudited, in millions, except per share data)\n\nNote 1 —  Segments\n\nThe Company conducts its business in the following two segments: Wet Shave and\nSun and Skin Care (collectively, the \"Segments,\" and each individually, a\n\"Segment\"). Segment performance is evaluated based on segment profit,\nexclusive of general corporate expenses, share-based compensation costs, items\nwhich are considered by the Company to be unusual or non-recurring and which\nmay have a disproportionate positive or negative impact on the Company's\nfinancial results in any particular period and the amortization of intangible\nassets. Financial items, such as interest income and expense, are managed on a\nglobal basis at the corporate level. The exclusion of such charges from\nsegment results reflects management's view on how it evaluates segment\nperformance.\n\nSegment net sales and profitability are presented below:\n                                            Three Months Ended                                           Nine Months Ended\n                                            June 30,                                                     June 30,\n                                            2026                              2025                       2026                         2025\n Net sales\n Wet Shave                                  $        312.8                    $        317.0             $       898.2                $         897.0\n Sun and Skin Care                          257.3                             243.4                      614.2                        595.1\n Total net sales                            $        570.1                    $        560.4             $    1,512.4                 $      1,492.1\n\n Segment Profit\n Wet Shave                                  $          34.9                   $          44.1            $       106.0                $         137.3\n Sun and Skin Care                          46.2                              46.0                       89.5                         93.4\n Total segment profit                       81.1                              90.1                       195.5                        230.7\n\n General corporate and other expenses       (21.9)                            (19.9)                     (66.0)                       (65.9)\n Amortization of intangibles                (6.2)                             (6.4)                      (19.0)                       (19.2)\n Interest and other expense, net            (7.0)                             (19.3)                     (37.7)                       (58.6)\n Restructuring and related costs            (24.5)                            (16.8)                     (71.9)                       (32.7)\n Acquisition and integration costs          —                                 —                          —                            (0.5)\n Sun Care reformulation costs               (0.7)                             (0.5)                      (3.4)                        (2.2)\n Legal matters                              —                                 —                          (5.7)                        —\n Gain on investment                         —                                 —                          1.5                          0.9\n Commercial realignment                     0.2                               0.1                        0.2                          (3.0)\n Other project and related costs            (3.0)                             1.2                        (4.5)                        (2.4)\n Total earnings (loss) before income taxes  $         18.0                    $         28.5             $      (11.0)                $         47.1\n\n Refer to Note 2 - GAAP to Non-GAAP Reconciliations below for the income\n statement location of non-GAAP adjustments to earnings before income taxes.\n\nNote 2 — GAAP to Non-GAAP Reconciliations\n\nThe following tables provide a GAAP to Non-GAAP reconciliation of certain line\nitems from the Condensed Consolidated Statement of Earnings:\n Three Months Ended June 30, 2026\n                                                  Gross Profit      SG&A              Operating            EBIT (Loss)                      Income Tax                      Net (Loss)             Diluted EPS\n                                                                                      Income               from                             Provision                       Income from            from\n                                                                                                           Continuing                       (Benefit)                       Continuing             Continuing\n                                                                                                           Operations( (1))                 from                            Operations             Operations\n                                                                                                                                            Continuing\n                                                                                                                                            Operations\n GAAP — Reported                                  $    242.5        $    108.3        $      25.0          $       18.0                     $        5.7                    $       12.3           $      0.26\n Restructuring and related costs                  11.2              (0.6)             24.5                 24.5                             6.0                             18.5                   0.40\n Sun Care reformulation costs                     —                 —                 0.7                  0.7                              0.1                             0.6                    0.01\n Commercial realignment                           (0.2)             —                 (0.2)                (0.2)                            (0.1)                           (0.1)                  —\n Other project and related costs                  0.1               (2.9)             3.0                  3.0                              0.8                             2.2                    0.05\n Total Adjusted Non-GAAP                          $    253.6        $    104.8        $      53.0          $       46.0                     $       12.5                    $       33.5           $      0.72\n\n                                                                                                           Adjusted Non-GAAP Constant Currency                                                     0.68\n\n GAAP as a percent of net sales                   42.5 %            19.0 %            4.4 %                GAAP effective tax rate                                                                 31.5 %\n Adjusted as a percent of net sales               44.5 %            18.4 %            9.3 %                Adjusted effective tax rate                                                             27.2 %\n Adjusted Constant Currency as a percent of net   44.1 %                              8.9 %\n sales\n (1) EBIT is defined as Earnings before Income taxes.\n\n \n Three Months Ended June 30, 2025\n                                     Gross Profit      SG&A               Operating          EBIT (Loss)                      Income Tax              Net (Loss)             Diluted EPS\n                                                                          Income             from                             Provision               Income from            from\n                                                                                             Continuing                       (Benefit)               Continuing             Continuing\n                                                                                             Operations( (1))                 from                    Operations             Operations\n                                                                                                                              Continuing\n                                                                                                                              Operations\n GAAP — Reported                     $    250.1        $    100.7         $     45.0         $       28.5                     $        7.0            $       21.5           $     0.46\n Restructuring and related costs     1.2               (0.6)              16.7               16.7                             4.1                     12.6                   0.27\n Sun Care reformulation costs        —                 —                  0.5                0.5                              0.1                     0.4                    0.01\n Commercial realignment              (0.1)             —                  (0.1)              (0.1)                            —                       (0.1)                  —\n Other project and related costs     —                 (1.5)              1.5                (1.2)                            (0.4)                   (0.8)                  (0.02)\n Total Adjusted Non-GAAP             $    251.2        $     98.6         $     63.6         $       44.4                     $       10.8            $       33.6           $     0.72\n\n GAAP as a percent of net sales      44.6 %            18.0 %             8.0 %              GAAP effective tax rate                                                         24.5 %\n Adjusted as a percent of net sales  44.8 %            17.6 %             11.3 %             Adjusted effective tax rate                                                     24.3 %\n (1) EBIT is defined as Earnings before Income taxes.\n\n \n Nine Months Ended June 30, 2026\n                                                  Gross Profit      SG&A              Operating            EBIT (Loss)                      Income Tax                      Net (Loss)             Diluted EPS\n                                                                                      Income               from                             Provision                       Income from            from\n                                                                                                           Continuing                       (Benefit)                       Continuing             Continuing\n                                                                                                           Operations( (1))                 from                            Operations             Operations\n                                                                                                                                            Continuing\n                                                                                                                                            Operations\n GAAP — Reported                                  $    620.4        $    321.7        $      24.5          $      (11.0)                    $        1.9                    $      (12.9)          $     (0.28)\n Restructuring and related costs                  25.7              (1.4)             71.9                 71.9                             17.7                            54.2                   1.17\n Sun Care reformulation costs                     —                 —                 3.4                  3.4                              0.8                             2.6                    0.06\n Legal matters                                    —                 (5.7)             5.7                  5.7                              1.4                             4.3                    0.09\n Gain on investment                               —                 —                 —                    (1.5)                            (0.3)                           (1.2)                  (0.03)\n Commercial realignment                           (0.2)             —                 (0.2)                (0.2)                            (0.1)                           (0.1)                  —\n Other project and related costs                  0.1               (5.1)             5.2                  4.5                              1.1                             3.4                    0.07\n Tax shortfall on equity compensation             —                 —                 —                    —                                (3.4)                           3.4                    0.07\n Total Adjusted Non-GAAP                          $    646.0        $    309.5        $    110.5           $       72.8                     $       19.1                    $       53.7           $      1.15\n\n                                                                                                           Adjusted Non-GAAP Constant Currency                                                     1.07\n\n GAAP as a percent of net sales                   41.0 %            21.3 %            1.6 %                GAAP effective tax rate                                                                 (17.0) %\n Adjusted as a percent of net sales               42.7 %            20.5 %            7.3 %                Adjusted effective tax rate                                                             26.3 %\n Adjusted Constant Currency as a percent of net   42.5 %                              6.9 %\n sales\n (1) EBIT is defined as Earnings (Loss) before Income taxes.\n\n \n Nine Months Ended June 30, 2025\n                                     Gross Profit      SG&A              Operating         EBIT (Loss)                      Income Tax             Net (Loss)             Diluted EPS\n                                                                         Income            from                             Provision              Income                 from\n                                                                                           Continuing                       (Benefit)              from                   Continuing\n                                                                                           Operations( (1))                 from                   Continuing             Operations\n                                                                                                                            Continuing             Operations\n                                                                                                                            Operations\n GAAP — Reported                     $    659.4        $    303.1        $    103.2        $       47.1                     $       15.0           $       32.1           $     0.67\n Restructuring and related costs     1.2               (0.6)             32.7              32.7                             8.0                    24.7                   0.50\n Acquisition and integration costs   —                 (0.5)             0.5               0.5                              0.1                    0.4                    0.01\n Sun Care reformulation costs        —                 —                 2.2               2.2                              0.5                    1.7                    0.04\n Gain on investment                  —                 —                 —                 (0.9)                            —                      (0.9)                  (0.02)\n Commercial realignment              3.0               —                 3.0               3.0                              0.9                    2.1                    0.04\n Other project and related costs     —                 (3.9)             3.9               2.4                              0.6                    1.8                    0.04\n Total Adjusted Non-GAAP             $    663.6        $    298.1        $    145.5        $       87.0                     $       25.1           $       61.9           $     1.28\n\n GAAP as a percent of net sales      44.2 %            20.3 %            6.9 %             GAAP effective tax rate                                                        31.7 %\n Adjusted as a percent of net sales  44.5 %            20.0 %            9.8 %             Adjusted effective tax rate                                                    28.8 %\n (1) EBIT is defined as Earnings before Income taxes.\n\nNote 3 - Net Sales and Profit (Loss) by Segment\n\nOperations for the Company are reported via two segments. The following tables\npresent changes in net sales and segment profit for the three and nine months\nended June 30, 2026, as compared to the corresponding period in the prior year\nquarter.\n Net Sales\n Quarter Ended June 30, 2026      Wet Shave                                 Sun and Skin Care                          Total\n Net sales -  Q3 2025             $      317.0                              $      243.4                               $      560.4\n Organic                          (6.1)                        (1.9) %      12.2                           5.0 %       6.1                        1.1 %\n Impact of currency               1.9                          0.6 %        1.7                            0.7 %       3.6                        0.6 %\n Net sales -  Q3 2026             $      312.8                 (1.3) %      $      257.3                   5.7 %       $      570.1               1.7 %\n\n Segment Profit\n Quarter Ended June 30, 2026      Wet Shave                                 Sun and Skin Care                          Total\n Segment profit -  Q3 2025        $        44.1                             $        46.0                              $        90.1\n Organic                          (10.9)                       (24.7) %     (0.7)                          (1.6) %     (11.6)                     (12.9) %\n Impact of currency               1.7                          3.8 %        0.9                            2.0 %       2.6                        2.9 %\n Segment profit -  Q3 2026        $        34.9                (20.9) %     $        46.2                  0.4 %       $        81.1              (10.0) %\n\n Net Sales\n Nine Months Ended June 30, 2026  Wet Shave                                 Sun and Skin Care                          Total\n Net sales -  Q3 2025             $      897.0                              $      595.1                               $    1,492.1\n Organic                          (19.8)                       (2.2) %      11.4                           1.9 %       (8.4)                      (0.6) %\n Impact of currency               21.0                         2.3 %        7.7                            1.3 %       28.7                       2.0 %\n Net sales -  Q3 2026             $      898.2                 0.1 %        $      614.2                   3.2 %       $    1,512.4               1.4 %\n\n Segment Profit\n Nine Months Ended June 30, 2026  Wet Shave                                 Sun and Skin Care                          Total\n Segment profit -  Q3 2025        $      137.3                              $        93.4                              $      230.7\n Organic                          (36.4)                       (26.5) %     (6.3)                          (6.8) %     (42.7)                     (18.5) %\n Impact of currency               5.1                          3.7 %        2.4                            2.6 %       7.5                        3.2 %\n Segment profit -  Q3 2026        $      106.0                 (22.8) %     $        89.5                  (4.2) %     $      195.5               (15.3) %\n\n For all tables, the impact of currency to segment profit includes both the\n translational and transactional currency changes during the quarter.\n\nNote 4 - Net Debt and EBITDA\n\nThe Company reports financial results on a GAAP and adjusted basis. The tables\nbelow are used to reconcile Net Debt and Net earnings to EBITDA and Adjusted\nEBITDA, which are non-GAAP measures, to improve comparability of results\nbetween periods.\n                                  June 30,                     September 30,\n                                  2026                         2025\n Notes payable                    $          34.2              $           29.5\n Long-term debt                   1,245.0                      1,383.3\n Gross debt                       1,279.2                      1,412.8\n Less: Cash and cash equivalents  397.1                        225.7\n Net debt                         $         882.1              $       1,187.1\n\n \n                                        Three Months Ended                                                   Nine Months Ended\n\nJune 30,\nJune 30,\n                                        2026                                  2025                           2026                                 2025\n Net Earnings                           $           12.3                      $           21.5               $          (12.9)                    $           32.1\n Income tax provision                   5.7                                   7.0                            1.9                                  15.0\n Interest expense, net                  14.8                                  19.0                           50.7                                 56.9\n Depreciation and amortization          18.6                                  18.3                           57.7                                 54.0\n EBITDA                                 51.4                                  65.7                           97.4                                 158.0\n\n Restructuring and related costs( (1))  24.0                                  16.3                           68.4                                 31.5\n Acquisition and integration costs      —                                     —                              —                                    0.5\n Sun Care reformulation costs           0.7                                   0.5                            3.4                                  2.2\n Legal matters                          —                                     —                              5.7                                  —\n (Gain) loss on investment              —                                     —                              (1.5)                                (0.9)\n Commercial realignment                 (0.2)                                 (0.1)                          (0.2)                                3.0\n Other project and related costs        3.0                                   (1.2)                          4.5                                  2.4\n Adjusted EBITDA                        $           78.9                      $           81.2               $          177.7                     $          196.7\n\n   (1)  Excludes $0.5 million and $3.5 million of accelerated depreciation, which is\n        included within Depreciation and amortization during the three and nine months\n        ended June 30, 2026, respectively and $0.6 million and $1.2 million during the\n        three and nine months ended June 30, 2025, respectively.\n\nNote 5 - Outlook for Continuing Operations\n\nThe following tables provide reconciliations of Adjusted EPS and Adjusted\nEBITDA, Non-GAAP measures, included within the Company's projected fiscal 2026\noutlook for continuing operations. The below outlook reflects management's\napproximate expectations and are subject to rounding adjustments. As a result,\nthe sum of individual amounts may not precisely equal the totals presented.\n Adjusted EPS Outlook\n Fiscal 2026 GAAP EPS                         approx.  $0.00 - $0.20\n\n Restructuring and related costs              approx.  1.96\n Sun Care reformulation costs                 approx.  0.11\n Legal Matter                                 approx.  0.12\n Gain on Investment                           approx.  (0.03)\n Other costs                                  approx.  0.13\n Income taxes((1))                            approx.  (0.49)\n\n Fiscal 2026 Adjusted EPS Outlook (Non-GAAP)  approx.  $1.80 - $2.00\n\n (1)     Income tax effect of the adjustments to Fiscal 2026 GAAP EPS noted above.\n\n \n Adjusted EBITDA Outlook\n Fiscal 2026 GAAP Net Income                  approx.  $0 - $10\n Income tax provision                         approx.  4\n Interest expense, net of $5 interest income  approx.  65\n Depreciation and amortization                approx.  77\n EBITDA                                       approx.  $146 - $156\n\n Restructuring and related costs( (2))        approx.  88\n Sun Care reformulation costs                 approx.  5\n Legal Matter                                 approx.  6\n Gain on Investment                           approx.  (1)\n Other costs                                  approx.  6\n Fiscal 2026 Adjusted EBITDA                  approx.  $250 - $260\n\n ((2))     Excludes accelerated depreciation, which is included within Depreciation and\n           amortization.\n\n \n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-third-quarter-fiscal-2026-results-302843031.html\n(https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-third-quarter-fiscal-2026-results-302843031.html)\n\nSOURCE Edgewell Personal Care Company\n\n\n\nCompany Contact: Chris Gough, Vice President, Investor Relations, 203-944-5706, Chris.Gough@Edgewell.com\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS384772/Edgewell-v1-Logo.jpg?id=OA2824444\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-08-05T10:00:01.065232026Z","server_sent_at_ms":1785924001065},"received_at":"2026-08-05T10:00:04.378Z","source_url":"https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-third-quarter-fiscal-2026-results-302843031.html"},"analysis":{"id":"98034","press_release_id":"109034","analysis_json":{"industry":{"label":"Household & Personal Products","sector":"Consumer Staples"},"redFlags":["GAAP EPS declined 43% YoY to $0.26","Gross margin decreased 210 basis points year-over-year to 42.5%","International organic sales declined 1.4%","Pre-tax restructuring costs of $24.5 million incurred in the quarter"],"eventType":"earnings","narrative":"Edgewell reported Q3 net sales of $570.1 million, up 1.7% year-over-year, with organic net sales returning to growth at 1.1% driven by a 3.0% increase in North America.\n\nAdjusted EPS came in at $0.72 and Adjusted EBITDA at $78.9 million, both exceeding expectations, while GAAP EPS declined to $0.26 due to restructuring charges and margin pressure.\n\nThe company narrowed its full-year outlook, maintaining midpoints for Adjusted EPS ($1.80-$2.00) and Adjusted EBITDA ($250-$260 million), and declared a quarterly dividend of $0.15 per share.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Edgewell returns to organic sales growth but GAAP profits slump on restructuring costs."},"keyFigures":{"eps":0.26,"revenue":"$570.1 million","guidance":"FY26 net sales +1.3-1.8%, Adj EPS $1.80-2.00, Adj EBITDA $250-260M","revenueYoy":"1.7%","customDimensions":{"adjusted_eps":0.72,"cash_on_hand":"$397.1 million","adjusted_ebitda":"$78.9 million","operating_income":"$25.0 million","gross_margin_gaap":"42.5%","dividend_per_share":"$0.15","organic_sales_growth":"1.1%","adjusted_gross_margin":"44.5%","adjusted_operating_income":"$53.0 million"}},"quotedText":"Our third quarter results represent an important step forward in our fiscal 2026 progression, with organic net sales returning to growth, meaningful improvement in North America, and adjusted EPS and adjusted EBITDA ahead of expectations","namedEntities":{"people":[{"name":"Rod Little","role":"President and Chief Executive Officer"},{"name":"Chris Gough","role":"Vice President, Investor Relations"}],"products":["Schick","Wilkinson Sword","Billie","Edge","Skintimate","Banana Boat","Hawaiian Tropic","Bulldog","Jack Black","CREMO","Wet Ones"],"companies":[{"name":"Edgewell Personal Care Company","ticker":"EPC"}],"dollarAmounts":[{"amount":"$570.1 million","context":"Third quarter net sales"},{"amount":"$397.1 million","context":"Cash on hand at end of quarter"},{"amount":"$418.8 million","context":"Available under U.S. revolving credit facility"},{"amount":"$7.0 million","context":"Dividends returned to shareholders in Q3"},{"amount":"$0.15 per common share","context":"Quarterly cash dividend declared"},{"amount":"$250 to $260 million","context":"Adjusted EBITDA outlook for FY2026"}]},"materialImpact":{"score":3,"reasoning":"The company returned to organic sales growth (1.1%) and beat expectations on Adjusted EPS and Adjusted EBITDA, signaling progress in its turnaround. However, GAAP EPS declined year-over-year and gross margins contracted, limiting the score despite the positive operational momentum."},"tickerRelevance":{"others":[],"primary":"EPC"},"globalImportance":30,"audienceRelevance":20,"eventTypeSecondary":["dividend","guidance_update"],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"earnings_with_adj_beat","sectorWeight":"consumer_staples"}},"event_type":"earnings","event_type_secondary":["dividend","guidance_update"],"sentiment":"bullish","material_impact_score":3,"narrative":"Edgewell reported Q3 net sales of $570.1 million, up 1.7% year-over-year, with organic net sales returning to growth at 1.1% driven by a 3.0% increase in North America.\n\nAdjusted EPS came in at $0.72 and Adjusted EBITDA at $78.9 million, both exceeding expectations, while GAAP EPS declined to $0.26 due to restructuring charges and margin pressure.\n\nThe company narrowed its full-year outlook, maintaining midpoints for Adjusted EPS ($1.80-$2.00) and Adjusted EBITDA ($250-$260 million), and declared a quarterly dividend of $0.15 per share.","key_figures":{"eps":0.26,"revenue":"$570.1 million","guidance":"FY26 net sales +1.3-1.8%, Adj EPS $1.80-2.00, Adj EBITDA $250-260M","revenueYoy":"1.7%","customDimensions":{"adjusted_eps":0.72,"cash_on_hand":"$397.1 million","adjusted_ebitda":"$78.9 million","operating_income":"$25.0 million","gross_margin_gaap":"42.5%","dividend_per_share":"$0.15","organic_sales_growth":"1.1%","adjusted_gross_margin":"44.5%","adjusted_operating_income":"$53.0 million"}},"named_entities":{"people":[{"name":"Rod Little","role":"President and Chief Executive Officer"},{"name":"Chris Gough","role":"Vice President, Investor Relations"}],"products":["Schick","Wilkinson Sword","Billie","Edge","Skintimate","Banana Boat","Hawaiian Tropic","Bulldog","Jack Black","CREMO","Wet Ones"],"companies":[{"name":"Edgewell Personal Care Company","ticker":"EPC"}],"dollarAmounts":[{"amount":"$570.1 million","context":"Third quarter net sales"},{"amount":"$397.1 million","context":"Cash on hand at end of quarter"},{"amount":"$418.8 million","context":"Available under U.S. revolving credit facility"},{"amount":"$7.0 million","context":"Dividends returned to shareholders in Q3"},{"amount":"$0.15 per common share","context":"Quarterly cash dividend declared"},{"amount":"$250 to $260 million","context":"Adjusted EBITDA outlook for FY2026"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-05T10:22:55.782Z","global_importance":30,"audience_relevance":20,"importance_components":{"tickerTier":"mid-cap","eventGravity":"earnings_with_adj_beat","sectorWeight":"consumer_staples"}},"durationMs":200839,"modelName":"glm-4.7"}}